Investments
Options
Stocks
ETFs
Fractional Shares
Cash Sweep
Features
Paper Trade
Charts
Stock Analysis
Level 2 Data
Moomoo Desktop
Market Analysis
Real-time Quotes
Stocks Market
Options Market
Futures Market
ETF Market
Forex Market
Technical Tools
Stock Screener
Heat Map
Earnings Calendar
Institutional Tracker
Trading News
Headlines
Latest News
Financial Calendar
Trending Topics
Video Analysis
Pricing
Pricing
Margin Rate
Promotions
Welcome Bonus
Moomoo Monday
Moomoo Million
Referral Promotion
Transfer Bonus
Resources
Strategies and Insights
Blogs
Moomoo Guide
Moomoo Tutorials
Moomoo Lessons
Investment Courses
Moomoo Community
Feed
Discussions
Featured Content
Support
About Us
About moomoo
Moomoo Highlights
Moomoo Foundation
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
More
Support
About Us
About moomoo
Moomoo Highlights
Moomoo Foundation
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
Log in
English
中文繁體
中文简体
Download
Mobile
moomoo Desktop
The next-gen workspace
Download now
Click to view more download content
Sign up/Log in
English
Back
Investments
Options
Stocks
ETFs
Fractional Shares
Cash Sweep
Features
Paper Trade
Charts
Stock Analysis
Level 2 Data
Moomoo Desktop
Market Analysis
Real-time Quotes
Stocks Market
Options Market
Futures Market
ETF Market
Forex Market
Technical Tools
Heat Map
Earnings Calendar
Institutional Tracker
Trading News
Headlines
Latest News
Financial Calendar
Trending Topics
Video Analysis
Pricing
Pricing
Margin Rate
Promotions
Welcome Bonus
Moomoo Monday
Moomoo Million
Referral Promotion
Transfer Bonus
Resources
Strategies and Insights
Blogs
Moomoo Guide
Moomoo Tutorials
Moomoo Lessons
Investment Courses
Moomoo Community
Feed
Discussions
Featured Content
Support
About Us
About moomoo
Moomoo Highlights
Moomoo Foundation
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
English
中文繁體
中文简体
Dark
Light
Open Account
Download
Log in to access Online Inquiry
Back to the Top
Jenna Ragan
Private
ID: 73075436
No Risk it, No Biscuit 🍪 Shop Smart. Shop S-Mart.
Follow
162
Following
551
Followers
4475
Visitors
Recommended Users
See More
Movers and Shakers
Recommend to you
50K followers
Follow
bullbull888
You may be interested
1645 followers
Follow
Dadacai
Love to share useful tips
31K followers
Follow
All
Original
Jenna Ragan
liked
·
1 hour ago
Baird Maintains Outperform on Allogene Therapeutics, Lowers Price Target to $9
Translate
Report
Jenna Ragan
liked
·
14 hours ago
Allogene Therapeutics 1Q Loss/Shr 28c >ALLO
1
Translate
Report
Jenna Ragan
liked
·
14 hours ago
Allogene Therapeutics Inc: Cash Runway Into 2H 2027
Translate
Report
Jenna Ragan
liked
·
14 hours ago
Allogene Therapeutics: Guidance 2025 Is Expected Decrease in Cash, Cash Equivalents, Investments of About $150 Mln
Translate
Report
Jenna Ragan
liked
·
21 hours ago
FibroGen Analyst Ratings
1
Translate
Report
Jenna Ragan
reacted to and commented on
intuitive Jackal_354
commented on a stock
·
21 hours ago
vwap then trump ?
$Invesco QQQ Trust (QQQ.US)$
3
2
Translate
Report
Jenna Ragan
:
Report
Reply
Cancel Reply
Jenna Ragan
liked
·
21 hours ago
Erasca Inc: Phase 1 Monotherapy Data for Eras-0015 & Eras-4001 Expected in 2026
Translate
Report
Jenna Ragan
shared
·
21 hours ago
$Erasca (ERAS.US)$
Erasca Seeks Partner for Naporafenib to Extend Cash Runway
Translate
Report
Jenna Ragan
liked
·
21 hours ago
Erasca Seeks Partner for Naporafenib to Extend Cash Runway
Translate
Report
Jenna Ragan
liked
·
Yesterday 23:09
HC Wainwright & Co. Reiterates Buy on FibroGen, Maintains $10 Price Target
Translate
Report
No content yet
Loading Failed
Refresh now
Loading...
Loading...
No visitors yet
Loading Failed
Refresh now
Can't view the content due to the user's privacy settings